Ciclum Farma, Unipessoal (a subsidiary of STADA Portugal) is a trusted partner in healthcare, striving to accelerate its success trajectory. STADA Portugal, a member of the STADA Group, operates globally, selling products in approximately 130 countries. As a reliable partner with over 120 years of experience, their focus on high-quality pharmaceutical products has established them as a trusted player in the industry. Their product portfolio includes well-known brands such as Nizoral, Hirudoid, Lactoflora, Hedrin, and Elmetacin, which are top sellers in their respective categories. With its headquarters in Bad Vilbel - Frankfurt, Germany, the success of the STADA Group can be attributed to its 10,400 employees worldwide. The company's core focus is on ensuring accessibility to quality healthcare through its generic products, thereby contributing to an enhanced quality of life for individuals. Moreover, the organization fosters an attractive work environment, offering opportunities for personal development and career advancement in the healthcare sector. Despite lacking recent investment data, Ciclum Farma, Unipessoal's alignment with STADA Portugal and its standing within the global STADA Group positions it as a promising entity with substantial growth potential within the Healthcare, Pharmaceutical, and Marketing sectors. For venture capitalists seeking opportunities in these industries, the company presents itself as an entity worth considering for potential investment or collaboration.
There is no investment information
No recent news or press coverage available for ciclum farma, unipessoal.